Management of High Blood Pressure with purgation therapy by using Aragwadhadi Avaleha

Clinical Evaluation of Virechan Karma of Aragwadhadi Avaleha in the Management of Hypertension - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081967

Enrollment

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with Hypertension. 2.Newly diagnosed patients having six month duration of stage 1 Essential Hypertension SBP(150-160mmHg)or DBP(90-100mmHg)of either sex between the age group of 18 to 60 years were include in this Research project.

Exclusion criteria

Exclusion criteria: 1.Patient having Stage 2 Hypertension with SBP(Greater than 180mmHg)or DBP(Greater than 110 mmHg). 2.Patient having Stage 1 Essential Hypertensionwith less than six months of durations. 3.Patients contraindicated for Virechan that are Bleeding hemorrhoids,chronic fissure in ano and irritable bowel syndrome.

Design outcomes

Primary

Measure	Time frame
Reduction in Lipid profile level.Timepoint: Base Line 30th day,60th day	—

Secondary

Measure	Time frame
Reduction in signs and symptoms of HypertensionTimepoint: Base Line 30th day,60th day	—

Countries

India

Contacts

Public ContactDr Santosh E Chavan

Bharati Vidyapeeth College Of Ayurved Pune

santosh.chavan@bharatividyapeeth.edu9822249807

Outcome results